In 1968 two reports were published describing children who showed features of both a mucopolysaccharidosis and a sphingolipidosis. ' 2 Initially described as a lipomucopolysaccharidosis,l this entity was later classified as mucolipidosis I when the term 'mucolipidosis' was introd-6ced as a common designation for a number of progressive disorders clinically related to both the mucopolysaccharidoses and the sphingolipidoses. 3 Subsequent studies revealed that patients with mucolipidosis I showed excessive intracellular accumulation and urinary excretion of sialic acid containing molecules in association with a neuraminidase (=sialidase) deficiency. 4 The demonstration that other patients with a somewhat different clinical course also showed a deficiency of neuraminidase activity prompted the publication of a comprehensive review and classification of the different forms of neuraminidase deficiency, also known as sialidosis.5 This classification incorporated several different entities, including mucolipidosis I, Goldberg's syndrome,6 and the cherry red spotmyoclonus syndrome.7 I D Young, E P Young, J Mossman, A R Fielder, and J R Moore talking at two years. At three years of age he was noted to have coarse facial features and a diagnosis of a mucopolysaccharidosis was considered, although there Normail raingc (n=31 intellect at the age of eight years. galactosidase deficiency lies in a glycoprotein normally required to protect these two enzymes against intralysosomal degradation. This contrasts with the defect in mucolipidosis types II and III in which there is believed to be a lack of recognition markers for targeting enzymes to lysosomes, so that activities of all lysosomal enzymes are low in cultured fibroblasts but raised in serum.
Thus, in summary, neuraminidase deficiency may present as at least five different disease entities. Affected sibs, parental consanguinity, and heterozygous levels in parents indicate that all of these entities show autosomal recessive inheritance. Prenatal diagnosis has been recorded for several types211 32 and should in principle be possible for all forms of neuraminidase deficiency. 44 It is hoped that this short review will enhance recognition of neuraminidase deficiency and enlighten those who, like the authors, find the nomenclature confusing. 
